Mrs Na Li

Shanghai Changzheng Hospital, Shanghai (China)

Follow

Contributor content

Efficacy and safety of Shexiang Baoxin pill in patients with ischemia with non-obstructive coronary arteries (LESS): a phase 4, multicenter, randomized, double-blind, placebo-controlled clinical trial

Presentation

Efficacy and safety of Shexiang Baoxin pill in patients with ischemia with non-obstructive coronary arteries (LESS): a phase 4, multicenter, randomized, double-blind, placebo-controlled clinical trial

ESC 365 is supported by

novartis

Explore sponsored resources